Submissions To China's Fast-Track System For Innovative Device Approval Swell
This article was originally published in Clinica
Executive Summary
The number of applications going through China’s fast-track regulatory process for evaluating innovative medical devices is growing at a steady pace with 46 products admitted for evaluation so far. Of these 17 were submitted in 2014 (of which six have been approved) and 29 in 2015 (of which two have been approved). The fast track route was launched by the China Food and Drug Administration on March 1, 2014.
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.